Tiziana Life Sciences (TLSA)
(Delayed Data from NSDQ)
$0.90 USD
0.00 (0.01%)
Updated Jul 23, 2024 03:58 PM ET
After-Market: $0.90 0.00 (-0.01%) 5:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TLSA 0.90 0.00(0.01%)
Will TLSA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TLSA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLSA
Buy Tesla Stock for Humanoid Robots and Full-Self Driving?
TLSA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TLSA
Tiziana Gains $3.4M Boost for Neurodegenerative Trials
Tiziana Life Sciences receives $3.4M in non-dilutive funding
Tiziana announces $3.4M non-dilutive funding
Tiziana Advances Alzheimer’s Treatment with FDA Nod
Tiziana Life to dose first patient with moderate Alzheimer's with foralumab